How to buy Inogen stock (INGN)

Inogen is a medical devices business based in the US. Inogen shares (INGN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.58 – an increase of 1.18% over the previous week. Inogen employs 834 staff and has a trailing 12-month revenue of around $331.5 million.

Our top picks for where to buy Inogen stock

Buy Inogen stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Inogen stock price (NASDAQ: INGN)

Use our graph to track the performance of INGN stocks over time.

Inogen shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$8.58
52-week range	$5.08 - $13.33
50-day moving average more info button	$9.42
200-day moving average more info button	$9.08
Wall St. target price	$10.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-2.25

Is it a good time to buy Inogen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Inogen price performance over time

Historical closes compared with the close of $8.6 from 2024-12-26

1 week (2024-12-20)	1.42%
1 month (2024-11-27)	-10.70%
3 months (2024-09-27)	-11.25%
6 months (2024-06-27)	7.90%

1 year (2023-12-27)	53.98%
2 years (2022-12-27)	-55.78%
3 years (2021-12-27)	33.52
5 years (2019-12-27)	68.54

Is Inogen stock undervalued or overvalued?

Valuing Inogen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inogen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Inogen's PEG ratio

Inogen's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.48. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Inogen's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Inogen financials

Revenue TTM	$331.5 million
Gross profit TTM	$153.5 million
Return on assets TTM	-9.66%
Return on equity TTM	-25.33%
Profit margin	-15.89%
Book value	$7.78
Market Capitalization more info button	$200.8 million

TTM: trailing 12 months

Inogen share dividends

We're not expecting Inogen to pay a dividend over the next 12 months.

Inogen share price volatility

Over the last 12 months, Inogen's shares have ranged in value from as little as $5.08 up to $13.3299. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inogen's is 1.045. This would suggest that Inogen's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Inogen overview

Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Frequently asked questions

null
What percentage of Inogen is owned by insiders or institutions?
Currently 1.842% of Inogen shares are held by insiders and 89.67% by institutions. How many people work for Inogen?
Latest data suggests 834 work at Inogen. When does the fiscal year end for Inogen?
Inogen's fiscal year ends in December. Where is Inogen based?
Inogen's address is: 859 Ward Drive, Goleta, CA, United States, 93111 What is Inogen's ISIN number?
Inogen's international securities identification number is: US45780L1044 What is Inogen's CUSIP number?
Inogen's Committee on Uniform Securities Identification Procedures number is: 45780L104